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people aged 10–24 years, 1950–2019: a systematic analysis 
for the Global Burden of Disease Study 2019
GBD 2019 Adolescent Mortality Collaborators*
Summary
Background Documentation of patterns and long-term trends in mortality in young people, which reflect huge 
changes in demographic and social determinants of adolescent health, enables identification of global investment 
priorities for this age group. We aimed to analyse data on the number of deaths, years of life lost, and mortality rates 
by sex and age group in people aged 10–24 years in 204 countries and territories from 1950 to 2019 by use of estimates 
from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019.
Methods We report trends in estimated total numbers of deaths and mortality rate per 100 000 population in young 
people aged 10–24 years by age group (10–14 years, 15–19 years, and 20–24 years) and sex in 204 countries and 
territories between 1950 and 2019 for all causes, and between 1980 and 2019 by cause of death. We analyse variation 
in outcomes by region, age group, and sex, and compare annual rate of change in mortality in young people aged 
10–24 years with that in children aged 0–9 years from 1990 to 2019. We then analyse the association between mortality 
in people aged 10–24 years and socioeconomic development using the GBD Socio-demographic Index (SDI), a 
composite measure based on average national educational attainment in people older than 15 years, total fertility rate 
in people younger than 25 years, and income per capita. We assess the association between SDI and all-cause 
mortality in 2019, and analyse the ratio of observed to expected mortality by SDI using the most recent available data 
release (2017).
Findings In 2019 there were 1·49 million deaths (95% uncertainty interval 1·39–1·59) worldwide in people aged 
10–24 years, of which 61% occurred in males. 32·7% of all adolescent deaths were due to transport injuries, 
unintentional injuries, or interpersonal violence and conflict; 32·1% were due to communicable, nutritional, or 
maternal causes; 27·0% were due to non-communicable diseases; and 8·2% were due to self-harm. Since 1950, 
deaths in this age group decreased by 30·0% in females and 15·3% in males, and sex-based differences in mortality 
rate have widened in most regions of the world. Geographical variation has also increased, particularly in people aged 
10–14 years. Since 1980, communicable and maternal causes of death have decreased sharply as a proportion of total 
deaths in most GBD super-regions, but remain some of the most common causes in sub-Saharan Africa and south 
Asia, where more than half of all adolescent deaths occur. Annual percentage decrease in all-cause mortality rate 
since 1990 in adolescents aged 15–19 years was 1·3% in males and 1·6% in females, almost half that of males aged 
1–4 years (2·4%), and around a third less than in females aged 1–4 years (2·5%). The proportion of global deaths in 
people aged 0–24 years that occurred in people aged 10–24 years more than doubled between 1950 and 2019, from 
9·5% to 21·6%.
Interpretation Variation in adolescent mortality between countries and by sex is widening, driven by poor progress in 
reducing deaths in males and older adolescents. Improving global adolescent mortality will require action to address 
the specific vulnerabilities of this age group, which are being overlooked. Furthermore, indirect effects of the 
COVID-19 pandemic are likely to jeopardise efforts to improve health outcomes including mortality in young people 
aged 10–24 years. There is an urgent need to respond to the changing global burden of adolescent mortality, address 
inequities where they occur, and improve the availability and quality of primary mortality data in this age group.
Funding Bill & Melinda Gates Foundation.
Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
Introduction
The most recent systematic global analysis to focus on 
mortality in young people aged 10–24 years is now more 
than a decade old.1 Since then, there have been huge 
changes to patterns of health risk, population growth, 
and improvements in the availability and quality of 
mortality estimates. There has also been wider 
recognition of the importance of adolescent health to 
global development,2,3 and in harnessing the demographic 
dividend resulting from forecasted population change.4 
Adolescents are now included within the UN Every 
Woman Every Child agenda,5 the Countdown to 2030 
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collaboration to track progress towards the Sustainable 
Development Goals (SDGs),6 and the work of the Global 
Financing Facility.7 Despite this progress, there is also 
growing concern that global adolescent health priorities 
are still neglected.8,9 Global progress to improve health 
outcomes for young people has been slow, and major 
challenges remain in addressing social determinants of 
adolescent health and mortality, such as unmet 
contraception need, child marriage, and access to quality 
secondary education.8 Furthermore, the COVID-19 
pandemic has ongoing consequences on the health of 
young people that are not fully understood. Although 
case fatality and morbidity due to COVID-19 is lower in 
young people than in older adults,10 this age group is 
particularly susceptible to indirect effects of the 
pandemic, with ongoing disruption to education and 
employment likely to further hinder progress in health.11
Mortality is a fundamental indicator of health12 and 
mortality estimates provide a proxy for broader health 
outcomes with little or no high quality data. This is 
particularly pertinent for young people, where data 
scarcity presents a barrier to understanding health needs 
in many countries,13,14 and the process of determining 
which metrics best capture adolescent health priorities is 
ongoing.15 Earlier work1 illustrated that global adolescent 
mortality is greater than previously recognised and that 
improvements lagged behind those seen in younger 
children,16 despite a high proportion of adolescent deaths 
being from preventable causes.17
Mortality is included in the indicator set for monitoring 
future progress in adolescent health. All-cause mortality 
in people aged 10–19 years is an indicator within the 
Global Strategy for Women’s, Children’s and Adolescents’ 
Health 2016–2030,5,18 and SDG 3 includes indicators for 
causes of death that are highly relevant to young people 
including maternal mortality (death due to complications 
during or after pregnancy; SDG indicator 3.1.1), suicide 
(3.4.2), and deaths due to road traffic injury (3.6.1).19
Agencies that provide adolescent mortality estimates for 
a broad range of countries include the UN Population 
Division, Department of Economic and Social Affairs,20 
WHO,21 US Census Bureau,22 and the UN Inter-agency 
Group for Child Mortality Estimation.23 However, the 
ongoing Global Burden of Diseases, Injuries, and Risk 
Factors Study (GBD) provides the only source of frequently 
updated, age-specific mortality estimates (including 
uncertainty intervals [UIs]) covering almost all countries 
and territories in the world.12 Furthermore, the availability 
Research in context
Evidence before this study
We searched PubMed and Embase for studies to answer the 
research question: “What are current global patterns and 
previous trends in mortality in adolescents and young people”. 
We used the following terms in titles or abstracts: (“adolescent” 
OR “young people” AND (“trends” OR “patterns”) AND (“death” 
OR “mortality”) AND (“world” OR “global” OR “international”). 
We found one study that focused on global mortality patterns 
in adolescents (10–24 years), published in 2009. Using data 
from 2004, this study reported the considerable burden of 
global adolescent mortality, and analysed geographic variation 
in outcomes, but did not explore trends over time. Two further 
studies reported trends in global mortality or years of life lost 
(YLLs) in adolescents and young people from 1990. As part of 
wider analyses of patterns of disease and risk factors in people 
aged 10–24 years, these studies found considerable variation in 
improvements in mortality and YLLs by country, age group, and 
sex. We identified other studies that examined adolescent 
deaths, but these either included smaller age groups 
(10–14 years, 10–19 years, or 15–24 years), focused on one 
region or group of countries, or were part of a wider study of 
mortality in other age groups and were not focused on 
adolescents. Although these studies provide useful insights into 
adolescent mortality, they do not provide a comprehensive 
global analysis of trends and burden of deaths in this age group.
Added value of this study
This is a comprehensive update of global mortality in young 
people aged 10–24 years, and the first analysis we are aware 
of to include estimates for 204 countries and territories, 
including all members and associate members of WHO. We 
found huge changes to adolescent mortality over the study 
period and increasing variation in outcomes. Mortality in 
people aged 10–24 years is increasing in many regions, 
particularly in males, and sex differences have widened in most 
regions of the world. Adolescent mortality rates were strongly 
associated with level of development. Demographic change and 
differences in mortality improvements are shifting the global 
burden of adolescent mortality towards sub-Saharan Africa, 
however, where communicable and maternal causes of death 
continue to predominate. We were able to identify countries 
with good adolescent mortality outcomes relative to their level 
of socioeconomic development, which can inform global health 
strategies for this age group.
Implications of all the available evidence
Despite increased recognition of the importance of adolescent 
health to global development and future economic prosperity, 
these findings highlight an ongoing failure to adequately 
respond to health risks during the adolescent years, and of 
funding levels that remain insufficient. This is compounded by 
rapid demographic change in low-resource settings where 
mortality hazards for adolescents remain high. Indirect effects of 
the COVID-19 pandemic threaten to restrict progress even 
further. Approaches must be developed to address growing 
inequities in mortality in this age group, and to focus on regions 
of the world and causes of death where improvements have 
stagnated. To monitor progress reliably, improvements in the 
quality and availability of adolescent health data are also 
urgently required.
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of estimates in GBD 2019 of all-cause mortality from 1950, 
and cause-specific estimates from 1980,12 provides a 
unique opportunity to analyse long-run trends over time, 
and so identify both successes and areas requiring global 
and national investment.
We use GBD 2019 estimates12 to analyse current and 
long-term trends in mortality in young people aged 
10–24 years globally and in 204 countries and territories. 
We use this age range to capture the social, biological, 
and neurocognitive transitions that occur during this 
stage of the life course,24 and use the terms adolescent 
and young person synonymously. This manuscript was 
produced as part of the GBD Collaborator Network and 
in accordance with the GBD Protocol.
Methods
Overview
We used data provided by the Institute for Health Metrics 
and Evaluation GBD 2019.12 Estimates were available for 
number of deaths, years of life lost (YLLs) and mortality 
rate per 100 000 population with UIs by sex and age 
group in 204 countries and territories. Mortality estimates 
for all causes were available from 1950 to 2019, and by 
cause of death from 1980 to 2019. GBD 2019 estimations 
are based on primary data from 86 249 sources, including 
civil registrations, vital statistics, censuses, disease 
notifications systems, and household surveys. The GBD 
2019 capstone papers and appendices describe these 
methods in detail,12 including procedures to standardise 
primary sources, redistribute non-specific or implausible 
causes of death, adjust for large spikes in mortality due 
to conflicts or natural disaster, and model estimates for 
locations that lack primary data. GBD 2019 complies with 
the Guidelines for Accurate and Transparent Health 
Estimates Reporting statement.25
GBD 2019 provides estimates for 281 underlying causes 
of death across a 4-level hierarchy, shown in appendix 1 
(table S2). Level 1 consists of three mutually exclusive 
and collectively exhaustive categories: communicable, 
maternal, neonatal, and nutritional diseases; non-com-
municable diseases; and injuries. Level 2 distinguishes 
these groups into 21 causes of death, (eg, neoplasms), 
with level 3 and then level 4 specifying underlying cause 
in greater detail. We report causes at level 2 of this 
hierarchy, but modified this to examine leading causes 
of death in young people aged 10–24 years in more 
detail. Firstly, we separated the level 2 group self-harm 
and interpersonal violence into two groups (self-harm 
[ie, suicide] and interpersonal violence and conflict). 
Secondly, due to the importance of maternal deaths in 
this age group, we separated the level 2 group maternal 
and neonatal disorders into its two level 3 causes 
(maternal disorders and neonatal disorders).
GBD 2019 mortality estimates were available for 
204 countries and territories (hereafter referred to as 
countries), which includes all members and associate 
members of WHO. Estimates were also available for 
21 GBD regions and 7 GBD super-regions (defined by 
both geography and income status). Here we primarily 
report outcomes by GBD super-region, with country-level 
and region-level estimates available in appendix 2. The 
seven GBD super-regions are central Europe, eastern 
Europe, and central Asia; Latin America and the 
Caribbean; southeast Asia, east Asia, and Oceania; north 
Africa and the Middle East; south Asia; sub-Saharan 
Africa; and high income. Note that separate from the 
high-income GBD super-region, there are countries 
defined as high income by the World Bank in all other 
GBD super-regions except sub-Saharan Africa and south 
Asia. However, when we discuss high-income countries 
in this analysis we are referring to the GBD high-income 
super-region. The list of countries included in the 
analysis, their GBD region, GBD super-region and World 
Bank income classification for 2021 is found in 
appendix 1 (table S1).
Analyses
We describe current and long-term trends in all-cause 
mortality rate and number of deaths from 1950 to 2019, 
by cause of death from 1980 to 2019; and by sex in people 
aged 10–14 years, 15–19 years, and 20–24 years. We 
analyse relative risk for mortality between age groups by 
dividing the mortality rate in people aged 20–24 years 
and people aged 15–19 years by the mortality rate in 
adolescents aged 10–14 years. We analyse variation in 
outcomes by sex by calculating the ratio of male to female 
all-cause mortality rate. We analyse between-country 
variation by calculating the ratio for all-cause mortality 
rate in people aged 10–24 years in the 90th to 10th centile 
countries globally to account for extreme values in some 
location-years.
We then analyse the relationship between mortality 
rate per 100 000 population in 2019 and country 
development status using the GBD Socio-demographic 
Index (SDI).26 The SDI is a summary indicator of social 
and economic conditions that are strongly correlated 
with health outcomes. An index value between 0 and 1 
is defined for three components: average national 
educational attainment in those older than 15 years, total 
fertility rate in those younger than 25 years, and lag-
distributed income per capita, using the observed 
minima and maxima over the estimation period for each 
component to set the scales. The composite SDI is the 
geometric mean of these indices for each location-year.26 
We analyse the strength of the association between SDI 
and all-cause mortality rate per 100 000 population by 
use of Spearman’s correlation coefficients. We then 
identified countries with mortality in young people that 
is lower or higher relative to their level of development. 
We did this by calculating the expected value of YLLs by 
age group and sex based solely on SDI for that location-
year using a generalised additive model with a Loess 
smoother on SDI.26 We then calculated the ratio of 
observed YLLs to the expected value according to country 
For more on GBD 2019 
estimation processes see 
www.healthdata.org
See Online for appendix 2
See Online for appendix 1
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SDI. We calculate YLLs as the sum of each death 
multiplied by the standard life expectancy at each age 
using GBD’s standard life table. Note these data were 
only available from 1990 to 2017.
Finally, we assess variation in progress to reduce 
mortality across the early life course, comparing trends 
and current mortality burden in young people aged 
10–24 years with infants younger than 1 year and children 
aged 1–4 years and 5–9 years. We first report annual rates 
of change between 1990 and 2019 for all-cause mortality 
rate for each country by 5-year age groups. We used the 
β coefficient from linear regression models of mortality 
rate per 100 000 population against time for each country 
to estimate annual rate of change (expressed as a 
percentage). We used these models rather than estimates 
at the start and end of each period to account for large 
fluctuations in country mortality due to war or natural 
disasters. We then identified countries with large 
differences in mortality performance by age group by 
comparing country-level all-cause mortality percentile in 
adolescents with that seen in children younger than 
5 years, as this age group has been the focus of global 
programming and experienced good mortality declines 
in recent years. Finally, we describe how the proportion 
of deaths in people younger than 25 years that occur in 
those aged 10–24 years changed between 1950 and 2019. 
All analyses were done in Stata 16 (StataCorp, College 
Station TX, USA).
Role of the funding source
The funder of this study had no role in study design, data 
collection, data analysis, data interpretation, or writing of 
the report.
Results
The table shows the number of global deaths and 
mortality rate per 100 000 population in 2019 by sex and 
GBD super-region for young people aged 10–24 years. 
Data by age group (10–14 years, 15–19 years, and 
20–24 years) can be found in appendix 1 (tables S3–S5), 
and country-level estimates are available in appendix 2 
(tables S1–S233).
Within a total global population of 1·86 billion people 
aged 10–24 years, there were around 1·49 million deaths 
in 2019 (95% UI 1·39–1·59). Just under half of these 
deaths occurred in people aged 20–24 years (692 000, 
95% UI 645 000–738 000), a third occurred in people aged 
15–19 years (499 000, 465 000–536 000), and a fifth 
occurred in people aged 10–14 years (299 000, 
276 000–325 000]. 51% of all people aged 10–24 years in 
2019 were male. 61·0% of all deaths in people aged 
10–24 years were in males (910 000, 847 000–974 000), 
with this proportion increasing with age (56·9% of 
deaths in people aged 10–14 years; 60·5% of deaths in 
people aged 15–19 years, and 63·2% of deaths in people 
aged 20–24 years). Most adolescent deaths in both sexes 
occurred in south Asia. The fewest adolescent deaths in 
Total deaths Rate per 100 000 people




Estimate 95% uncertainty 
interval
Females
Global 581 311 531 162–634 825 100% 63·99 58·47–69·88
Central Europe, eastern 
Europe, and central Asia
13 032 12 042–14 207 2·2% 36·70 33·92–40·01
High income 19 715 19 532–19 913 3·4% 21·28 21·09–21·50
Latin America and Caribbean 33 376 29 924–37 078 5·7% 46·19 41·41–51·31
North Africa and Middle East 38 862 34 148–45 205 6·7% 49·81 43·77–57·95
South Asia 224 137 196 768–253 694 38·6% 88·05 77·30–99·67
Southeast Asia, east Asia, 
and Oceania
68 295 61 737–75 149 11·7% 34·82 31·47–38·31
Sub-Saharan Africa 183 893 159 437–213 930 31·6% 102·57 88·93–119·33
Males
Global 909 678 846 675–974 477 100% 95·41 88·80–102·20
Central Europe, eastern 
Europe, and central Asia
31 263 28 845–33 776 3·4% 83·56 77·10–90·28
High income 48 600 48 045–49 176 5·3% 49·85 49·28–50·44
Latin America and Caribbean 96 676 87 477–107 076 10·6% 130·62 118·19–144·67
North Africa and Middle East 73 335 64 813–83 549 8·1% 88·07 77·84–100·34
South Asia 253 999 224 664–286 215 27·9% 93·64 82·82–105·51
Southeast Asia, east Asia, 
and Oceania
157 271 141 742–173 199 17·3% 73·31 66·07–80·74
Sub-Saharan Africa 248 533 220 401–279 643 27·3% 141·60 125·57–159·32
Table: Deaths in people aged 10–24 years in 2019 by sex and GBD super-region
Figure 1: Global number of deaths in people aged 10–24 years from 1950 to 2019 by sex and age group
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both sexes were reported in Central Europe, eastern 
Europe, and central Asia. Mortality rates in 2019 
increased with age across adolescence in all regions of 
the world, particularly in males, but with considerable 
variation. Within GBD super-regions, the relative risk of 
mortality in young adulthood (20–24 years) compared 
with early adolescence (10–14 years) ranged from 6·6 in 
the high-income GBD super-region in males to 1·9 in 
north Africa and the Middle East in females.
In 2019, the mortality rate per 100 000 in young people 
aged 10–14 years ranged from 7·32 (95% UI 6·90–7·78) 
in Denmark to 187·25 (165·74–217·44) in Central African 
Republic in males, and from 6·01 (5·79–6·25) in 
Denmark to 115·73 (107·50–129·23) in Central African 
Republic in females. The mortality rate in young people 
age 15–19 years ranged from 22·55 (21·50–23·72) in 
Denmark to 370·28 (305·42–448·95) in Lesotho in males, 
and 12·15 (12·02–12·29) in Japan to 248·02 
(169·99–348·35) in Lesotho in females. The mortality 
rate in people aged 20–24 years ranged from 36·24 
(35·48–37·05) in Singapore to 559·77 (434·53–670·69) in 
Lesotho in males and 14·44 (14·05–14·85) in Singapore 
to 445·22 (303·38–636·53) in Lesotho in females 
(appendix 1, figures S6–S11; appendix 2, tables S1–S233).
Globally, 32·7% of deaths in young people aged 
10–24 years in 2019 were due to transport injuries, 
unintentional injuries, or interpersonal violence or 
conflict; 32·1% were due to communicable, nutritional, 
or maternal causes; 27·0% were due to non-communicable 
diseases; and 8·2% were due to self-harm. However, 
there was large variation in the leading causes of 
adolescent death by GBD super-region, sex, and age. In 
males aged 10–14 years, the most common cause of death 
was unintentional injury in all GBD super-regions except 
high income, where neoplasms were the leading cause of 
death, and south Asia and sub-Saharan Africa, where 
enteric infections were the leading cause of death. In 
males aged 15–24 years, the most common cause of death 
was transport injury in all GBD super-regions except 
Latin America and the Caribbean, where the leading 
cause of death was interpersonal violence and conflict, 
and central Europe, eastern Europe and central Asia, 
where the leading cause of death was self-harm 
(appendix 1, tables S50–S112).
The leading causes of death in females aged 10–14 years 
were neoplasms (Latin America and the Caribbean; central 
Europe, eastern Europe, and central Asia; and high 
income), unintentional injury (southeast Asia, east Asia, 
and Oceania), enteric infections (south Asia) and transport 
injuries (north Africa and the Middle East). In females 
aged 15–19 years, the leading causes of death were 
transport injuries (high income; north Africa and the 
Middle East; and southeast Asia, east Asia, and Oceania), 
self-harm (south Asia and central Europe, eastern Europe, 
and central Asia), interpersonal violence and conflict (Latin 
America and the Caribbean). The most frequent causes of 
death in females aged 20–24 years were transport injuries 
(high income), neoplasms (southeast Asia, east Asia, and 
Oceania and central Europe, eastern Europe, and central 
Asia), interpersonal violence and conflict (Latin America 
and the Caribbean), cardiovascular diseases (north Africa 
and the Middle East), and self-harm (south Asia). 
HIV/AIDS and sexually transmitted infections were the 
leading causes of death in sub-Saharan Africa in females 
in all adolescent age groups. Although not the leading 
cause in any GBD super-region, maternal death was still in 
the three most common causes of death in females aged 
20–24 years in sub-Saharan Africa, north Africa and the 
Figure 2: Mortality rate per 100 000 population in people aged 10–24 years from 1950 to 2019 by sex and 
GBD super-region
GBD=Global Burden of Diseases, Injuries, and Risk Factors Study.
Global
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Middle East, and south Asia, and was the fourth most 
common cause of death in Latin America and the 
Caribbean.
Annual global deaths in adolescents aged 10–24 years 
reduced by 21·7% between 1950 and 2019, during which 
time the world population in this age group increased by 
157% (figure 1; appendix 1, figure S2). The largest 
decrease in deaths was in females (30·0%, vs 15·3% in 
males) despite similar population growth (154% in 
females and 161% in males). There were also large 
differences in trends in deaths by age group; in children 
aged 10–14 years, deaths decreased by 37·5% in males 
and 37·9% in females; in people aged 15–19 years, deaths 
decreased by 17·8% in males and 27·9% in females; and 
in people aged 20–24 years, deaths decreased by 26·9% 
in females and increased by 0·8% in males.
In young people aged 10–14 years, deaths decreased 
between 1950 and 2019 in all GBD super-regions except 
sub-Saharan Africa, where deaths increased by 140·6% 
in males and 144·3% in females. The largest decrease in 
deaths since 1950 in young people aged 10–14 years were 
in high-income countries (86·0% reduction in males 
and 87·3% reduction in females). In males aged 
15–24 years, deaths increased in all GBD super-regions 
except high income; central Europe, eastern Europe, and 
central Asia; and southeast Asia, east Asia, and Oceania. 
The greatest increase in deaths in males aged 15–24 years 
was in sub-Saharan Africa, where deaths increased 
by 180·5% in males aged 15–19 years and 218·2% in 
males aged 20–24 years. The greatest decrease in deaths 
in males aged 15–24 years was in the high-income GBD 
super-region, where deaths decreased by 72·6% in males 
aged 15–19 years and 66·0% in males aged 20–24 years. 
In females aged 15–24 years, deaths decreased in all 
GBD super-regions except north Africa and the Middle 
East and sub-Saharan Africa. The greatest increase in 
deaths in females aged 15–24 years was in sub-Saharan 
Africa in both females aged 15–19 years (175·7% increase) 
and 20–24 years (164·3% increase). The greatest decrease 
in deaths in females aged 15–24 years was in high-
income countries in both females aged 15–19 years 
(81·0% decrease) and 20–24 years (79·9% decrease).
Figure 2 shows mortality rate per 100 000 population in 
people aged 10–14 years, 15–19 years, and 20–24 years by 
sex and GBD super-region between 1950 and 2019. 
In people aged 10–14 years, global mortality rates reduced 
by 74·6% in males and 74·3% in females, with the 
greatest relative change in mortality in high-income 
countries (reduction of 88·2% in males and 89·0% in 
females). The GBD super-region with the smallest relative 
change in mortality rate was sub-Saharan Africa, with 
reductions of 65·4% in males and 63·9% in females. All 
other regions had a 72–88% reduction in mortality rate 
over this period in males and females aged 10–14 years.
Global mortality rate per 100 000 population in people 
aged 15–19 years decreased by 68·7% in males and 
71·7% in females between 1950 and 2019. The region 
with the greatest relative reduction in mortality in this 
age group was southeast Asia, east Asia, and Oceania, 
where the mortality rate declined by 80·1% in males and 
86·1% in females. The region with the lowest relative 
reduction in mortality rate was sub-Saharan Africa, with 
relative reductions of 57·8% in males and 59·4% 
in females.
Global mortality rate per 100 000 population in people 
aged 20–24 years reduced by 63·4% in males and 
72·7% in females between 1950 and 2019. Relative 
declines in mortality were greatest in southeast Asia, east 
Asia, and Oceania, with reductions of 77·7% in males 
and 86·4% in females. In males aged 20–24 years, the 
lowest relative decline was in central Europe, eastern 
Europe, and central Asia, where mortality rates reduced 
by 46·1% since 1950. Among females aged 20–24 years, 
the lowest relative reduction in mortality was seen in 
sub-Saharan Africa, where mortality rates decreased 
by 60·7%.
In 2019, the ratio of male to female mortality rate per 
100 000 population was 1·2 for people aged 10–14 years, 
1·5 for people aged 15–19 years, and 1·7 for people aged 
20–24 years (appendix 1, figure S20). Mortality rate per 
100 000 people aged 10–24 years was higher in males in all 
regions of the world except south Asia, where outcomes 
were similar. Sex differences in mortality were greatest 
in Latin America and the Caribbean in people aged 
20–24 years, where the mortality rate per 100 000 in males 
Figure 3: Ratio of mortality rate per 100 000 population in the 90th centile country to 10th centile country 
in people aged 10–24 years between 1950 and 2019 by sex and age group
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was more than three times that in females. The ratio of 
male to female mortality rate increased between 1950 and 
2019 for older adolescents aged 15–24 years in all GBD 
super-regions except high income and central Europe, 
eastern Europe, and central Asia, where it has reduced 
since the mid-1990s.
Inequality in mortality rate per 100 000 population 
between countries was reported using the ratio of 
mortality rate for the highest decile country (90th centile) 
to lowest decile country (10th centile) in each year. In 
2019, variations in mortality by country were greatest 
in adolescents aged 10–14 years, with the mortality rate in 
the 90th centile country around 9 times higher than that 
in the 10th centile country for both males and females. 
Inequality in outcomes by country has also increased 
over time for all age groups since 1950, although this 
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seems to have decreased in females aged 20–24 years 
since around 2000 (figure 3).
The percentage of total deaths by cause from 1980 
to 2019 in each GBD super-region is shown in figure 4 
for young people aged 10–14 years, 15–19 years, 
and 20–24 years. Bump charts that rank cause of 
death between 1980 and 2019 for each age group, 
sex, and GBD super-region are shown in appendix 1 
(figures S50–S112).
We report large reductions in the contribution of 
communicable and maternal causes to total adolescent 
deaths between 1980 and 2019 in Latin America and the 
Caribbean; south Asia; southeast Asia, east Asia, and the 
Caribbean; and north Africa and the Middle East. 
Figure 4: Percentage of total deaths by cause in people aged 15–19 years from 1980 to 2019 by sex and GBD super-region
(A) Females (B) Males. GBD=Global Burden of Diseases, Injuries, and Risk Factors Study.
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Furthermore, although maternal deaths still contribute a 
substantial proportion of global deaths in females aged 
20–24 years, this has fallen substantially since 1980. 
Maternal deaths halved as a proportion of total deaths 
between 1980 and 2019 in southeast Asia, east Asia, and 
Oceania; north Africa and the Middle East; and central 
Europe, eastern Europe, and central Asia, with large 
reductions also seen in south Asia and Latin America 
and the Caribbean. However, in sub-Saharan Africa, the 
five most common causes of death in 2019 in females 
aged 10–24 years were communicable or maternal 
causes, with communicable causes contributing to three 
of the top five causes in males. HIV/AIDS and sexually 
transmitted diseases have been the leading causes of 
death in this GBD super-region in females aged 
15–24 years since the early 1990s, and in females aged 
10–14 years since the early 2000s.
In central Europe, eastern Europe, and central Asia, self-
harm rose from the third highest cause of death in males 
aged 15–24 years in 1980 to be the leading cause of death 
(now contributing to more than 20% of all deaths), and 
from fourth highest to the leading cause of death in females 
aged 15–19 years and second highest cause of death in 
females aged 20–24 years. In males aged 10–14 years, self-
harm is now the fourth most common cause of death in 
this super-region (almost 9% of all deaths). By contrast, 
in southeast Asia, east Asia, and Oceania, self-harm in 
females aged 15–24 years fell from the leading cause of 
death in 1980 (around 15% of all deaths), to sixth highest in 
females aged 15–19 years and seventh highest in females 
aged 20–24 years in 2019 (around 7% of all deaths in both 
age groups). In the high-income GBD super-region, deaths 
due to substance misuse disorders in young adults aged 
20–24 years rose from around 1% of total deaths in 1980 to 
14–16% in 2019 in both sexes, with substantial increases 
also seen in people aged 15–19 years.
Increasing SDI in 2019 was strongly associated with 
lower all-cause mortality rate per 100 000 people in all 
adolescent age groups (appendix 1, table S6). Figure 5 
shows the ratio of observed to expected YLLs by SDI 
from all causes for people aged 15–19 years in 2017. 
Equivalent figures for people aged 10–14 years and 
20–24 years are shown in appendix 1 (figures S26–28), 
with estimates from 1990 to 2017 for all countries 
shown in appendix 1 (figures S29–S49). Observed YLLs 
from all causes in people aged 15–19 years were at least 
20% higher than expected by level of SDI in 41 countries, 
including both Brazil and Pakistan, which collectively 
contribute to around 10% of deaths in this age group. In 
people aged 15–19 years, the ratio of observed to 
expected YLLs in 2017 was highest in Syria (4·02), but 
from 1990 to 2010 (before the start of the civil war), 
observed YLLs in Syria were consistently around 
30% lower than expected by level of SDI. 84 countries 
had observed YLLs in people aged 15–19 years at least 
20% lower than expected by level of SDI. The countries 
with the lowest ratio of observed to expected YLLs in 
this age group were the Maldives (0·30), Spain (0·33), 
and Singapore (0·35). Other notable countries included 
China (0·49) and Ethiopia (0·67), which together 
contribute more than 7% of global deaths in people aged 
15–19 years.
Annual percentage decline in mortality rate per 
100 000 population in infants younger than 1 year and 
children and young people aged 1–4 years, 5–9 years, 
10–14 years, 15–19 years, and 20–24 years by sex, country, 
and globally between 1990 and 2019 is shown in figure 6. 
Rates of decline were highest in children aged 1–4 years 
and lowest in young people aged 15–24 years. In children 
aged 1–4 years, global mortality rates decreased by around 
2·4% per year since 1990 in both males and females, 
compared with people aged 15–19 years, in whom 
mortality rates decreased by 1·3% in males and 1·6% in 
females. The range in mortality rate change between 
countries was also greater in adolescents than in younger 
children (appendix 1, figure S24).
Figure 5: Ratio of observed to expected years of life lost by Sociodemographic Index from all causes in people aged 15–19 years in 2017 from 195 countries
Ratio of observed
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Mortality rate performance varied within countries for 
different age groups, particularly in males. Figure 7 shows 
mortality rate percentile for males younger than 5 years 
compared with males aged 15–19 years for each country 
in 2019, with the equivalent figure for females shown in 
appendix 1 (figure S25). Although in most countries the 
mortality rate percentiles for these age groups are similar, 
there are notable exceptions. For example, in Brazil and 
Venezuela, mortality rates for males younger than 5 years 
are around the 60th centile but in the 90th centile for 
males aged 15–19 years. Similarly, mortality rates in 
Ukraine and Thailand are around the 30th centile for 
children younger than 5 years, but above the 75th centile 
for young people aged 15–19 years. By contrast, the 
mortality rate in India for people younger than 5 years is 
around the 70th centile, and between the 30th and 
40th centiles for those aged 15–19 years.
Figure 8 shows the proportion of global deaths in 
people aged 0–24 years that occur in people aged 
10–24 years. This proportion increased from 9·5% in 
1950 to 21·6% by 2019 and increased in all GBD super-
regions between 1950 and 2019, with the greatest change 
seen in Latin America and the Caribbean in males (from 
7·5% to 39·2%). In the high-income GBD super-region, 
deaths in adolescence now account for more than half of 
all deaths before 25 years of age. In nine countries 
(Estonia, Thailand, Saudi Arabia, Finland, Puerto Rico, 
Slovenia, Monaco, Cook Islands, and Andorra), more 
than 70% of deaths in males younger than 25 years now 
occur in people aged 10–24 years.
Discussion
Despite marked reductions in total numbers of deaths 
and mortality rates for adolescents over the past 70 years, 
improvements have lagged behind those seen in younger 
children, variation in outcomes between countries has 
increased, and inequities by sex have worsened. Global 
numbers of deaths in adolescence remain high, at 
around 4000 each day, most of which are from preventable 
causes.
Figure 6: Annual percentage change in mortality rate per 100 000 population in people aged 0–24 years 1990–2019 by sex, age group, and GBD 
super-region
The dashed line represents global annualised percentage change in mortality rate. Each coloured dot represents the percentage change in a single year for each 
country, coloured by GBD super-region. Data for Rwanda (both sexes, 15–19 years) and Bosnia and Herzegovina (females aged 1–4 years) are excluded as the range 
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We found widening variation in all-cause mortality 
between countries, particularly during early adolescence, 
and huge differences in the leading causes of death 
between different regions of the world, as others have 
reported.17,27 Variation in all-cause mortality between 
countries seems likely to increase further, as population 
growth in this age group is highest in countries with the 
worst mortality outcomes (appendix 1, figures S21–S23). 
Around 20% of people aged 10–24 years live in sub-
Saharan Africa, and this is set to rise to a third by 2050,4 
which presents huge challenges to the improvement of 
adolescent mortality. Of the ten countries with the 
highest mortality rates in this age group, eight are in sub-
Saharan Africa, and decreases have been far slower than 
in other GBD super-regions. These changes are shifting 
the global burden of adolescent mortality towards sub-
Saharan Africa, where 29·0% of deaths in adolescents 
now occur, compared with 8·1% in 1950. Sub-Saharan 
Africa has already replaced south Asia as the main 
contributor to global deaths in males aged 10–19 years, 
and is set to do the same in males aged 20–24 years and 
females aged 10–19 years if current trends continue.
We found marked sex differences in adolescent 
mortality, with notably higher mortality and slower rates 
of decline in young men than in young women. Indeed, 
more adolescent males died in 2019 than adolescent 
females in 1950, and inequalities in mortality by sex also 
seem to be widening in many regions of the world. 
These differences reflect the increasing burden of deaths 
Figure 7: Percentiles of mortality rate per 100 000 population in males aged younger than 5 years and 15–19 years in 2019 by country and GBD super-region
Size of each mark is proportional to the population of males aged 15–19 years. Due to space constraints, not all countries are labelled. GBD=Global Burden of Diseases, Injuries, and Risk Factors Study.
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Figure 8: Proportion of deaths in people younger than 25 years occurring in 
adolescents aged 10–24 years in 1950 and 2019
The size of each plot is proportional to the total number of deaths in people 
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due to injuries and violence in this age group, particularly 
in Latin America and the Caribbean, and the rise in 
deaths due to substance misuse in high-income settings, 
which predominantly affect young men. Addressing 
inequities in access to health services, the social 
conditions in which young women live, and the impact 
of gender-based violence are fundamental to improving 
adolescent health globally and have understandably 
been the focus of previous programming.19 However, 
inequitable gender norms are also damaging to 
adolescent males, and advancing the health of all 
adolescents requires action to reduce inequities in 
outcomes wherever they occur.
Consistent with previous studies,14,16,17,27 we found 
declines in adolescent mortality to have been slower than 
in younger children, particularly in males (annualised 
decrease in mortality in males aged 1–4 years almost 
twice that in males aged 15–19 years, and annualised 
decrease in mortality in females aged 1–4 years about 
50% higher than in females aged 15–19 years).
A previous analysis16 of long-term mortality trends 
using WHO estimates found that differences in mortality 
reduction by age resulted in people aged 15–24 years 
replacing those aged 1–4 years as the group with the 
highest mortality burden in many countries. 15–19 years 
was highlighted as the age group with the slowest 
mortality decline among people aged 0–19 years using 
GBD data,27 and Masquelier and colleagues14 found that 
the decrease in mortality in children aged 5–9 years 
exceeded that in young people aged 10–14 years between 
1990 and 2016 using estimates from the UN.14 The 
continued neglect of this age group is highlighted by 
several (mostly middle-income) countries such as Brazil 
and Mexico having good outcomes for children aged 
0–4 years but persistently high adolescent mortality 
(figure 7), which suggests that more adolescent-specific 
interventions are needed in these settings. Almost a 
quarter of deaths in people aged 0–24 years now occur in 
people aged 10–24 years, and this proportion has more 
than doubled since 1950. In high-income countries, these 
account for almost half of deaths before 25 years of age, 
and in countries with particularly high mortality due to 
violence, adolescent deaths now account for up to three-
quarters of early life course mortality.
This poor progress in reducing mortality might reflect 
the omission of adolescents from most global health 
investments. Adolescents were largely absent from the 
Millennium Development Goal (MDG) agenda, and 
although they will have benefited from public health 
interventions aimed at other groups, they have not had 
the accelerated decreases in mortality seen in infants 
and younger children that is attributed to MDG 
programming.27 The SDGs include indicators that are 
highly relevant to young people, but do not provide a 
comprehensive mechanism to address the unique health 
needs of this age group,27 and a list of metrics to best 
capture global adolescent health priorities has not yet 
been defined.15 The 2016 Global Strategy for Women’s, 
Children and Adolescents’ Health and other initiatives 
have increased recognition of the crucial role of 
adolescents to the sustainable development agenda and 
global targets for Universal Health Coverage.5 However, 
investment remains inadequate, and specific challenges 
to improvement of adolescent health outcomes and 
achieving core Universal Health Coverage indicators in 
this age group continue to be overlooked.8,9
These factors are compounded by limited evidence for 
effective adolescent health interventions needed to 
inform investment.28 A key focus to improve outcomes in 
this age group should be to address these knowledge 
gaps and better establish which interventions work, 
guided by identifying and measuring key indicators that 
capture adolescent health priorities.15 Investment in 
existing evidenced-based actions to prevent causes of 
death that predominate during adolescence is also likely 
to improve outcomes, but is currently inadequate. This 
should include improving water safety; preventing 
unintentional injuries;29 and targeting key behavioural, 
legal, and structural risk factors for road traffic deaths.30,31 
However, global increases in injury prevention spending 
have been lower than those on other public health 
interventions32 and progress towards reducing road 
traffic deaths in line with SDG targets is insufficient.30 
Self-harm has emerged as a leading cause of adolescent 
mortality, and now accounts for around 20% of all deaths 
in people aged 15–24 years in the high-income and 
central Europe, eastern Europe, and central Asia GBD 
super-regions. Self-harm is also the leading cause of 
death in south Asia for females aged 15–24 years and 
second highest cause for males aged 20–24 years. 
Although understanding these trends is complex and 
solutions to improve outcomes need to be country-
specific, investment in evidence-based interventions to 
improve mental health in this age group33,34 and measures 
to restrict access to firearms and chemicals used in 
suicide are likely to be beneficial.35,36 However, global 
improvements to the quality and accessibility of mental 
health services have been slow, disproportionately 
affecting adolescents and young people.34 Furthermore, 
strategies to improve outcomes for communicable and 
maternal causes of death, which still contribute to around 
a third of global deaths in people aged 10–24 years, also 
need to be specifically tailored for this age group.37 
Although evidence-based interventions around 
adolescent sexual and reproductive health are available, 
these are mainly focused on high-income countries, and 
knowledge gaps remain.38
We found several large spikes in mortality over the 
study period, particularly in older male adolescents, as a 
result of violent conflict and natural disasters. Deaths 
due to interpersonal violence are also impeding progress 
in reduction of all-cause mortality in males in many 
countries, particularly in Latin America and the 
Caribbean where there has been little to no improvement 
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in all-cause mortality in males aged 15–24 years over the 
past 20 years. Global strategies to improve adolescent 
health outcomes must include efforts to mitigate the 
effect of interpersonal violence and conflicts on young 
people. Existing humanitarian response guidance 
highlights specific vulnerabilities of adolescents during 
natural disasters and conflict.39 However, the evidence 
base to manage these in low-income and middle-income 
countries remains weak,40 and further work is required to 
understand adolescent health needs in these situations.
Reducing mortality in young people also requires an 
understanding of the broader social determinants of 
adolescent health, and how structural changes such as 
rapid urbanisation and technological and economic 
development might affect young people differently from 
other age groups. The importance of primary education 
to population health is well described, but national 
progress in secondary education is also associated with 
large improvements in all-cause mortality and other 
important health outcomes for young people.41 The 
increasing numbers of adolescents growing up in urban 
settings could extend opportunities for education, in 
addition to potential economic benefits for young people 
and their families. However, rapid, unplanned 
urbanisation can also increase health risks that are 
pertinent to adolescents, including those related to 
injury, separation from family support through 
migration, exposure to violence, substance misuse, and 
unsafe employment.2,42 The effect of other macro-level 
health determinants seems to differ across the early life 
course, with national wealth a weaker predictor of 
mortality in adolescents than it is in young children.43 
Indeed, for some common causes of death in 
adolescents (eg, road injuries), rapid economic growth 
can result in a transient increase in mortality, as the 
introduction of safety legislation and appropriate 
infrastructure might lag behind rising demand for 
transportation.44,45 By contrast, inequality in income 
distribution within countries seems to be pervasively 
harmful throughout the early life course, and thus 
might be of greater relative importance to outcomes 
during adolescence.43
Our data are limited by factors inherent in the 
production of GBD mortality estimates, and by the 
availability of authoritative mortality data for adolescents. 
Global coverage of civil registration systems is of varying 
quality, and progress to improve these systems has been 
minimal.46 Primary data sources for adolescents are 
particularly scarce, as attempts to develop alternative 
methods to measure mortality have focused on other 
groups.13 Data availability and accuracy are further 
impeded by ongoing conflicts and associated migration 
in many countries. Where data are available, there are 
often long delays in reporting outcomes. Analysis of the 
global adolescent mortality burden is therefore reliant on 
modelled data, and the estimates we report here need to 
be viewed within that context. Limitations within the 
GBD estimation process and the paucity of mortality data 
for this age group are reflected in wide UIs for many 
time periods, locations, and causes of death.
Using alternative data sources with different modelling 
techniques might have provided different results. 
Estimates for global number of deaths in people aged 
10–24 years in 2019 produced by the UN Interagency 
Group for Child Mortality Estimation were 8–19% higher 
than GBD 2019 (appendix 1, figures S113–S115), and 
10–20% lower than those in the World Population 
Prospects report.20 Although variation in available 
mortality estimates for high-income countries have been 
highlighted,47 the main discrepancies are within sub-
Saharan Africa, where the future global burden of 
mortality in adolescents will be concentrated. This 
further highlights the need to expand primary data 
collection for adolescent health outcomes in this region.
We used SDI to identify countries with lower or higher 
adolescent mortality than would be expected from country 
income per capita, years in education, and fertility younger 
than 25 years; indicators for socioeconomic development 
that are particularly relevant for adolescents. However, 
other disaggregated metrics of development could provide 
additional insights, and further detailed analyses are 
required to explore the contribution of trends in key social 
determinants on adolescent mortality, which are likely to 
vary in different regions of the world. We report estimates 
at the country level, and future analyses of adolescent 
mortality should include sub-national trends. Where these 
are available within GBD they have wide variation in 
outcomes. Using level 2 of the GBD cause of death 
hierarchy allows a description of high-level trends in 
mortality in young people, but further analyses using 
more granular cause of death data are needed to increase 
understanding of the patterns we describe. Analysis of 
associations between health-care quality and adolescent 
mortality by use of the Healthcare Access and Quality 
Index48 provided by GBD could provide further insights, 
and looking beyond mortality and describing key trends in 
morbidity in young people should also be the focus of 
future study.
This analysis does not include the impact of the 
COVID-19 pandemic on young people. Although 
susceptibility to SARS-CoV-2 in young people is similar 
to that in older groups,49 case fatality has been much 
lower than in older adults,10 and the direct effect on 
mortality in this age group is likely to be small. More 
concerning are the indirect effects of COVID-19 on the 
future health of young people, particularly through 
disruption to health services caused by the pandemic, the 
impact on opportunities for education and employment 
and related consequences to health and nutrition, and 
the exacerbation of existing inequalities.50 The ongoing 
closure of schools and universities in many countries 
will have lasting effects on the health of young people. 
Further, this age group are more likely to work in sectors 
vulnerable to restrictions introduced during the 
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pandemic than are older adults, and at a greater risk of 
losing employment and reporting reduced earnings. 
There is some evidence to suggest that young people 
have been more affected by worsening mental health 
than older adults, and concern that suicide risk in early 
adolescence might have increased.51,52 Broader effects of 
the pandemic to key adolescent health determinants are 
likely to include those related to economic instability, 
conflict, and failing to prioritise the climate crisis.53 The 
extent to which these determinants will affect wellbeing 
in young people, and prospects to improve health 
outcomes including mortality, are not understood and 
warrant further study.
Our findings reveal a persistant failure by policy 
makers to adequately address global health risks during 
adolescence or respond to changes in the global burden 
of early life course mortality. Despite increased 
understanding of the importance of adolescents to global 
development, funding remains insufficient and the 
challenge to improve outcomes is increasing. Investment 
in this age group builds on health improvements 
achieved in younger children, will affect future adult 
health trajectories and those of the next generation,3 and 
will be an important determinant of future economic 
development.2,17,54 Renewed emphasis is urgently needed 
to reduce inequities in outcomes in this age group, 
improve the availability and quality of primary data, and 
establish mechanisms to use these data to better inform 
global health policy, focusing on regions of the world 
where mortality is increasing.
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